220 related articles for article (PubMed ID: 19287181)
1. Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis.
Xu G; Tu W; Jiang D; Xu C
Nephron Clin Pract; 2009; 111(4):c223-8. PubMed ID: 19287181
[TBL] [Abstract][Full Text] [Related]
2. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
[TBL] [Abstract][Full Text] [Related]
3. A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome.
Wang XB; Dai EL; Xue GZ; Ma RL
Medicine (Baltimore); 2018 Jul; 97(27):e11282. PubMed ID: 29979395
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
Tao X; Cush JJ; Garret M; Lipsky PE
J Rheumatol; 2001 Oct; 28(10):2160-7. PubMed ID: 11669150
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
[TBL] [Abstract][Full Text] [Related]
6. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on effect of Tripterygium wilfordii Hook. f. on uterin leiomyoma].
Gao Y; Chen D
Zhonghua Fu Chan Ke Za Zhi; 2000 Jul; 35(7):430-2. PubMed ID: 11776193
[TBL] [Abstract][Full Text] [Related]
8. Fingerprint chromatogram analysis of extracts from the leaves of Tripterygium wilfordii Hook. F. by high performance liquid chromatography.
Li K; Wang S
J Sep Sci; 2005 May; 28(7):653-7. PubMed ID: 15912735
[TBL] [Abstract][Full Text] [Related]
9. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.
Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL
Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
[TBL] [Abstract][Full Text] [Related]
12. Tripterygium wilfordii Hook F as Maintenance Treatment for Crohn's Disease.
Sun J; Shen X; Dong J; Wang H; Zuo L; Zhao J; Zhu W; Li Y; Gong J; Li J
Am J Med Sci; 2015 Nov; 350(5):345-51. PubMed ID: 26473333
[TBL] [Abstract][Full Text] [Related]
13. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial.
Zhu W; Li Y; Gong J; Zuo L; Zhang W; Cao L; Gu L; Guo Z; Li N; Li J
Dig Liver Dis; 2015 Jan; 47(1):14-9. PubMed ID: 25445405
[TBL] [Abstract][Full Text] [Related]
14. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
Tao X; Cai JJ; Lipsky PE
J Pharmacol Exp Ther; 1995 Mar; 272(3):1305-12. PubMed ID: 7891348
[TBL] [Abstract][Full Text] [Related]
15. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis.
Canter PH; Lee HS; Ernst E
Phytomedicine; 2006 May; 13(5):371-7. PubMed ID: 16487688
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.
Luo D; Zuo Z; Zhao H; Tan Y; Xiao C
Front Med; 2019 Oct; 13(5):556-563. PubMed ID: 30604167
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders].
Pan XD; Chen XC
Yao Xue Xue Bao; 2008 Dec; 43(12):1179-85. PubMed ID: 19244746
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial.
Wu C; Jin HZ; Shu D; Li F; He CX; Qiao J; Yu XL; Zhang Y; He YB; Liu TJ
Chin Med J (Engl); 2015 Feb; 128(4):443-9. PubMed ID: 25673443
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
Jin D; Yu M; Li X; Wang X
J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
